Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.

Furuhashi M, Ishimura S, Ota H, Hayashi M, Nishitani T, Tanaka M, Yoshida H, Shimamoto K, Hotamisligil GS, Miura T.

PLoS One. 2011;6(11):e27356. doi: 10.1371/journal.pone.0027356. Epub 2011 Nov 10.

2.

Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation.

Ota H, Furuhashi M, Ishimura S, Koyama M, Okazaki Y, Mita T, Fuseya T, Yamashita T, Tanaka M, Yoshida H, Shimamoto K, Miura T.

Am J Hypertens. 2012 Oct;25(10):1124-30. doi: 10.1038/ajh.2012.88. Epub 2012 Jun 21.

3.

Serum retinol-binding protein 4 as a marker for cardiovascular disease in women.

Alkharfy KM, Al-Daghri NM, Vanhoutte PM, Krishnaswamy S, Xu A.

PLoS One. 2012;7(10):e48612. doi: 10.1371/journal.pone.0048612. Epub 2012 Oct 31.

4.

Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients.

Arsov S, Trajceska L, van Oeveren W, Smit AJ, Dzekova P, Stegmayr B, Sikole A, Rakhorst G, Graaff R.

Artif Organs. 2013 Jul;37(7):E114-22. doi: 10.1111/aor.12078. Epub 2013 May 2.

PMID:
23635017
5.

Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study.

von Eynatten M, Breitling LP, Roos M, Baumann M, Rothenbacher D, Brenner H.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2327-35. doi: 10.1161/ATVBAHA.112.248609. Epub 2012 Jun 7.

6.

Plasma-free fatty acids, fatty acid-binding protein 4, and mortality in older adults (from the Cardiovascular Health Study).

Miedema MD, Maziarz M, Biggs ML, Zieman SJ, Kizer JR, Ix JH, Mozaffarian D, Tracy RP, Psaty BM, Siscovick DS, Mukamal KJ, Djousse L.

Am J Cardiol. 2014 Sep 15;114(6):843-8. doi: 10.1016/j.amjcard.2014.06.012. Epub 2014 Jul 1.

7.

Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients.

Masuda T, Murata M, Honma S, Iwazu Y, Sasaki N, Ogura M, Onishi A, Ando Y, Muto S, Shimada K, Kario K, Kusano E, Asano Y.

Nephrol Dial Transplant. 2011 Jul;26(7):2289-95. doi: 10.1093/ndt/gfq756. Epub 2011 Jan 10.

8.

Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.

Sahinarslan A, Güz G, Okyay K, Mutluay R, Yalçin R, Bali M, Sindel S, Cengel A.

Turk Kardiyol Dern Ars. 2008 Sep;36(6):382-7.

9.

Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease.

Hsu BG, Chen YC, Lee RP, Lee CC, Lee CJ, Wang JH.

Circ J. 2010 Feb;74(2):327-31. Epub 2009 Dec 14.

10.

Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.

Helal I, Smaoui W, Hamida FB, Ouniss M, Aderrahim E, Hedri H, Elyounsi F, Maiz HB, Abdallah TB, Kheder A.

Saudi J Kidney Dis Transpl. 2010 Jan;21(1):59-62.

11.

Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.

Fukuoka K, Nakao K, Morimoto H, Nakao A, Takatori Y, Arimoto K, Taki M, Wada J, Makino H.

Nephrology (Carlton). 2008 Jun;13(4):278-83. doi: 10.1111/j.1440-1797.2007.00864.x.

PMID:
18476915
12.

Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up.

Desideri G, Panichi V, Paoletti S, Grassi D, Bigazzi R, Beati S, Bernabini G, Rosati A, Ferri C, Taddei S, Ghiadoni L; RISCAVID investigators.

Nephrol Dial Transplant. 2011 Sep;26(9):2983-8. doi: 10.1093/ndt/gfq823. Epub 2011 Feb 8.

13.

Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population.

Fuseya T, Furuhashi M, Yuda S, Muranaka A, Kawamukai M, Mita T, Ishimura S, Watanabe Y, Hoshina K, Tanaka M, Ohno K, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K, Miura T.

Cardiovasc Diabetol. 2014 Aug 21;13:126. doi: 10.1186/s12933-014-0126-7.

14.

The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines.

Park SE, Rhee EJ, Lee WY, Kim WJ, Yoo SH, Bae JC, Choi ES, Park CY, Oh KW, Park SW, Kim SW.

Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):525-32. doi: 10.1016/j.numecd.2010.09.008. Epub 2010 Dec 24.

PMID:
21186114
15.

Adiponectin and cardiovascular outcomes among hemodialysis patients.

Abdallah E, Waked E, Nabil M, El-Bendary O.

Kidney Blood Press Res. 2012;35(4):247-53. doi: 10.1159/000334649. Epub 2012 Jan 26.

PMID:
22286012
16.

Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.

Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B.

Am J Kidney Dis. 2006 Jan;47(1):139-48.

PMID:
16377395
17.

Body fat percentage as a risk factor for atherosclerosis but not for inflammation for hemodialysis patients: differences between genders.

Sezer S, Karakan S, Saşak G, Tutal E, Ozdemir Acar FN.

J Ren Nutr. 2012 Sep;22(5):490-8. doi: 10.1053/j.jrn.2011.09.001. Epub 2011 Dec 6.

PMID:
22153383
18.

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS.

Circulation. 2002 Mar 19;105(11):1354-9. Erratum in: Circulation 2002 May 7;105(18):2230. Cateliotti A [corrected to Cataliotti A].

19.

Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.

Selim G, Stojceva-Taneva O, Spasovski G, Georgievska-Ismail L, Zafirovska-Ivanovska B, Gelev S, Dzekova P, Trajcevska L, Trojacanec-Piponska S, Sikole A.

Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8.

PMID:
21757955
20.

Apelin: a peptide involved in cardiovascular risk in hemodialysis patients?

Leal VO, Lobo JC, Stockler-Pinto MB, Farage NE, Calixto A, Geloneze B, Mafra D.

Ren Fail. 2012;34(5):577-81. doi: 10.3109/0886022X.2012.668490. Epub 2012 Mar 15.

PMID:
22417287
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk